Case Report: Successful Treatment of Recurrent Urinary Tract Infection Due to Extensively Drug-Resistant Klebsiella Pneumoniae in a Kidney Transplant Recipient Using Chloramphenicol.

[1]  R. Luzzati,et al.  Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice , 2020, Antibiotics.

[2]  E. Heil,et al.  The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms , 2020, Current Infectious Disease Reports.

[3]  Jian-Hua Liu,et al.  Emergent Polymyxin Resistance: End of an Era? , 2019, Open forum infectious diseases.

[4]  D. Calfee,et al.  Antimicrobial resistance in nephrology , 2019, Nature Reviews Nephrology.

[5]  C. H. Camargo,et al.  The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  A. Moreno,et al.  Managing recurrent urinary tract infections in kidney transplant patients , 2018, Expert review of anti-infective therapy.

[7]  J. Kirby,et al.  Screening for synergistic activity of antimicrobial combinations against carbapenem-resistant Enterobacteriaceae using inkjet printer-based technology , 2017, The Journal of antimicrobial chemotherapy.

[8]  Matthew D. Johnson,et al.  Synergistic killing of NDM-producing MDR Klebsiella pneumoniae by two 'old' antibiotics-polymyxin B and chloramphenicol. , 2015, The Journal of antimicrobial chemotherapy.

[9]  L. Leibovici,et al.  Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials. , 2015, The Journal of antimicrobial chemotherapy.

[10]  T. Welte,et al.  Multidrug-resistant bacteria in solid organ transplant recipients. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  Ju-Yeun Lee,et al.  Colistin resistance in Klebsiella pneumoniae. , 2014, International journal of antimicrobial agents.

[12]  S. Di Bella,et al.  Could chloramphenicol be used against ESKAPE pathogens? A review of in vitro data in the literature from the 21st century , 2014, Expert review of anti-infective therapy.

[13]  Neil Woodford,et al.  What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. , 2011, International journal of antimicrobial agents.

[14]  A. Oliver,et al.  Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations. , 2018, Transplantation reviews.

[15]  M. Tumbarello,et al.  Optimizing therapy in CRE infections. , 2018, Current opinion in infectious diseases.

[16]  A. Bertrand.  [Chloramphenicol and thiamphenicol]. , 1988, La Revue du praticien.